Shanghai Microport Medbot Group
Shanghai MicroPort MedBot Group Co Ltd is a Chinese medical device company dedicated to surgical robotic systems. The company researches, develops, and commercializes surgical robots spanning laparoscopic, orthopedic, vascular, natural orifice, and percutaneous procedures. Main revenue drivers include commercial sales of the Toumai laparoscopic surgical system and Honghu orthopedic surgical robot, alongside training services and maintenance contracts. MicroPort MedBot serves hospitals, surgical centers, and healthcare providers across China and international medical markets. The company holds a pioneering market position as a leading native surgical robotics enterprise in China. Headquartered in Shanghai, China, Shanghai MicroPort MedBot Group Co Ltd is listed on the Hong Kong Stock Exchange.
5 of the funds FundTelligence covers report a position in Shanghai Microport Medbot Group.
- Legal name
- Shanghai Microport Medbot Group Co
- Sector
- Health Care
- Country
- China
- Funds holding it
- 5
- Exposure themes
- Healthcare, Robotics & Automation, Surgical Robotics
Funds holding Shanghai Microport Medbot Group
- DNB Fund Asian Mid Cap — DNB · 0.6 % (full portfolio disclosed, September 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.1 % (full portfolio disclosed, October 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)